1-3 of 3
Mary Mathieu
Close
Sort by
Journal Articles

An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia

Steven R. Leong, Siddharth Sukumaran, Maria Hristopoulos, Klara Totpal, Shannon Stainton, Elizabeth Lu, Alfred Wong, Lucinda Tam, Robert Newman, Brian R. Vuillemenot, Diego Ellerman, Chen Gu, Mary Mathieu, Mark S. Dennis, Allen Nguyen, Bing Zheng, Crystal Zhang, Genee Lee, Yu-Waye Chu, Rodney A. Prell, Kedan Lin, Steven T. Laing, Andrew G. Polson
Journal: Blood
Blood (2017) 129 (5): 609–618.
https://doi.org/10.1182/blood-2016-08-735365
Published: 2017
Includes: Supplemental data
Journal Articles

Preclinical Characterization of Combinability and Potential Synergy of Anti-CD20/CD3 T-Cell Dependent Bispecific Antibody with Chemotherapy and PD-1/PD-L1 Blockade

Liping Laura Sun, PhD, Peiyin Wang, Robyn Clark, Maria Hristopoulos, Diego Ellerman, PhD, Mary Mathieu, Yu-Waye Chu, Hong Wang, PhD, Klara Totpal, PhD, Allen J. Ebens, PhD, Andrew G. Polson, PhD, Stephen Gould, PhD
Journal: Blood
Blood (2016) 128 (22): 4168.
https://doi.org/10.1182/blood.V128.22.4168.4168
Published: 2016
Journal Articles

Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies

L. Laura Sun, PhD, Xiaocheng Chen, Yvonne Chen, Mark S. Dennis, Diego Ellerman, PhD, Clarissa Johnson, Mary Mathieu, Amy Oldendorp, Andrew G. Polson, PhD, Arthur Reyes, Eric Stefanich, Hong Wang, PhD, Peiyin Wang, Bing Zheng, Allen J. Ebens, PhD
Journal: Blood
Blood (2014) 124 (21): 4507.
https://doi.org/10.1182/blood.V124.21.4507.4507
Published: 2014